Zhejiang Shengda Bio-Pharm Co., Ltd. (603079.SS)
CNY 16.65
(-2.06%)
CNY 16.65
(-2.06%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 119.2 Million CNY | 9.72% |
| 2022 | 108.64 Million CNY | -28.64% |
| 2021 | 152.25 Million CNY | -20.79% |
| 2020 | 192.21 Million CNY | 58.1% |
| 2019 | 121.57 Million CNY | 13.72% |
| 2018 | 106.91 Million CNY | 20.46% |
| 2017 | 88.75 Million CNY | -22.79% |
| 2016 | 114.94 Million CNY | -25.24% |
| 2015 | 153.74 Million CNY | 94.62% |
| 2014 | 78.99 Million CNY | -0.55% |
| 2013 | 79.43 Million CNY | -43.35% |
| 2012 | 140.22 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 31.98 Million CNY | 22.13% |
| 2024 Q3 | 32.2 Million CNY | 9.09% |
| 2024 Q2 | 32.24 Million CNY | 0.8% |
| 2023 Q4 | 26.19 Million CNY | -13.05% |
| 2023 FY | 119.2 Million CNY | 9.72% |
| 2023 Q1 | 26.94 Million CNY | 152.38% |
| 2023 Q2 | 35.95 Million CNY | 33.44% |
| 2023 Q3 | 30.12 Million CNY | -16.22% |
| 2022 Q3 | 36.98 Million CNY | 2.57% |
| 2022 Q1 | 24.92 Million CNY | -50.54% |
| 2022 Q2 | 36.05 Million CNY | 44.66% |
| 2022 FY | 108.64 Million CNY | -28.64% |
| 2022 Q4 | 10.67 Million CNY | -71.14% |
| 2021 Q2 | 35.07 Million CNY | 24.26% |
| 2021 Q4 | 50.39 Million CNY | 30.68% |
| 2021 FY | 152.25 Million CNY | -20.79% |
| 2021 Q1 | 28.22 Million CNY | -46.39% |
| 2021 Q3 | 38.56 Million CNY | 9.97% |
| 2020 FY | 192.21 Million CNY | 58.1% |
| 2020 Q4 | 52.64 Million CNY | -0.79% |
| 2020 Q3 | 53.06 Million CNY | -6.0% |
| 2020 Q2 | 56.45 Million CNY | 87.9% |
| 2020 Q1 | 30.04 Million CNY | -27.01% |
| 2019 Q1 | 19.94 Million CNY | -44.06% |
| 2019 Q2 | 26.18 Million CNY | 31.26% |
| 2019 Q4 | 41.16 Million CNY | 20.04% |
| 2019 Q3 | 34.28 Million CNY | 30.96% |
| 2019 FY | 121.57 Million CNY | 13.72% |
| 2018 Q1 | 19.38 Million CNY | -31.83% |
| 2018 Q3 | 30.24 Million CNY | 39.82% |
| 2018 Q4 | 35.65 Million CNY | 17.9% |
| 2018 FY | 106.91 Million CNY | 20.46% |
| 2018 Q2 | 21.63 Million CNY | 11.59% |
| 2017 FY | 88.75 Million CNY | -22.79% |
| 2017 Q2 | 17.24 Million CNY | -9.36% |
| 2017 Q4 | 28.43 Million CNY | 18.26% |
| 2017 Q1 | 19.02 Million CNY | -37.16% |
| 2017 Q3 | 24.04 Million CNY | 39.44% |
| 2016 Q3 | 33.25 Million CNY | 0.0% |
| 2016 FY | 114.94 Million CNY | -25.24% |
| 2016 Q4 | 30.27 Million CNY | -8.97% |
| 2015 Q2 | 32.83 Million CNY | 0.0% |
| 2015 Q1 | 32.83 Million CNY | 0.0% |
| 2015 FY | 153.74 Million CNY | 94.62% |
| 2014 FY | 78.99 Million CNY | -0.55% |
| 2013 FY | 79.43 Million CNY | -43.35% |
| 2012 FY | 140.22 Million CNY | 0.0% |